Mohs Micrographic Surgery
Treatment for Non-melanoma skin cancer (squamous-cell carcinoma)
Effectiveness
98%
Safety Score
75%
Clinical Trials
4
Participants
150K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
75
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
Single procedure
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$400
Side Effect Mgmt:$100
Total Annual:$3,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$30,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$3,571
Cost per Remission
$3,571
Comparison vs Surgical Excision
Cost Difference
+$1,000/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Mohs Micrographic Surgery Outcomes
for Non-melanoma skin cancer (squamous-cell carcinoma)
Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+98%
Common Side Effects
Pain
+30%
Swelling/Bruising
+40%
Infection
+3%
Scarring
+100%
Nerve damage (temporary/permanent)
+2%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
3 active trials recruiting for Mohs Micrographic Surgery in Non-melanoma skin cancer (squamous-cell carcinoma)
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT05108090RECRUITINGNA
94 participants
INTERVENTIONAL
Indianapolis, United States
Started: Oct 25, 2021
Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
NCT07241585NOT YET RECRUITINGNA
54 participants
INTERVENTIONAL
Cleveland, United States
Started: May 1, 2026
Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma
NCT06782399NOT YET RECRUITINGEARLY_PHASE1
25 participants
INTERVENTIONAL
Started: Jul 1, 2025